National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 384838

History of Changes from the VAERS Wayback Machine

First Appeared on 5/11/2010

VAERS ID: 384838
VAERS Form:
Age:0.3
Sex:Female
Location:Foreign
Vaccinated:2008-02-12
Onset:2008-02-17
Submitted:2010-04-09
Entered:2010-04-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / GLAXOSMITHKLINE BIOLOGICALS A20CA391B / - GM / SC
HIBV: HIB (HIBERIX) / GLAXOSMITHKLINE BIOLOGICALS A20CA391B / - GM / SC
IPV: POLIO VIRUS, INACT. (NO BRAND NAME) / UNKNOWN MANUFACTURER A20CA391B / - GM / SC
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA526A / 0 - / PO

Administered by: Other      Purchased by: Other
Symptoms: Apathy, Barium double contrast, Diet refusal, Echography abnormal, Flatulence, Intussusception, Vomiting, Subileus, Bowel movement irregularity

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Pyrimethamine; Sulphadiazine; Calcium folinate
Current Illness: Unknown
Preexisting Conditions: Congenital Toxoplasmosis; The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. No family history of intestinal invagination. There was a family functional colopathy.
Allergies:
Diagnostic Lab Data: Echography, 17Feb2008, Abnormal; 17 February 2008: The echography revealed an ileocaecal intestinal invagination with mesenteric ganglions. Reduction of invagination by gastrografin enema, controlled on post reduction echography.
CDC 'Split Type': B0509703A

Write-up: This case was reported by a physician, via a GSK sales representative and described the occurrence of invagination of intestine in a 3-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Concurrent medical condition included treated congenital toxoplasmosis (NOS). The subject had no past medical condition of intestinal malformation and intestinal invagination. There was a family functional colopathy. In February 2008, the subject received a 1st dose of ROTARIX (batch number not available). On 17 February 2008, 14 days after vaccination with ROTARIX, the subject was hospitalized. At the echography, a diagnosis of ileocaecal invagination of intestine with mesenteric ganglions was made. The subject was treated with enema and the subject recovered. The hospital physicians evoked a possible relation between toxoplasmosis and mesenteric ganglions. The physician considered the events were unrelated to vaccination with ROTARIX (temporal association but non causal). Follow up received on 12 March 2008: The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. There was no family history of intestinal invagination. Medical condition included congenital toxoplasmosis (maternal antibodies became positive during the pregnancy), treated with ADIAZINE and pyrimethamine since birth. On 12 February 2008, the subject received a first dose of ROTARIX (batch number A41CA526A) and a dose of INFANRIX QUINTA (batch number A20CA391B, right gluteal, subcutaneous). Five days later, on 17 February 2008, the subject developed moderate occlusive syndrome (intestinal obstruction) with vomiting and cessation of feces and flatus. Diagnosis of acute intestinal (ileocaecum) invagination was made on echography. No abdominal scan and X-ray was performed. The intestinal invagination was reduced by gastrografin enema, controlled on post reduction echography. ROTARIX has not been readministered. The reporter considered that the events were possibly related to vaccination


Changed on 7/31/2010

VAERS ID: 384838 Before After
VAERS Form:
Age:0.3
Sex:Female
Location:Foreign
Vaccinated:2008-02-12
Onset:2008-02-17
Submitted:2010-04-09
Entered:2010-04-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / GLAXOSMITHKLINE BIOLOGICALS A20CA391B / - GM / SC
DTAPIPVHIB: DTAP + IPV + HIB (UNKNOWN) / GLAXOSMITHKLINE BIOLOGICALS (UNKNOWN) A20CA391B / - GM / SC
HIBV: HIB (HIBERIX) / GLAXOSMITHKLINE BIOLOGICALS A20CA391B / - GM / SC
IPV: POLIO VIRUS, INACT. (NO BRAND NAME) / UNKNOWN MANUFACTURER A20CA391B / - GM / SC
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA526A / 0 - / PO

Administered by: Other      Purchased by: Other
Symptoms: Apathy, Barium double contrast, Diet refusal, Echography abnormal, Flatulence, Intussusception, Vomiting, Subileus, Bowel movement irregularity

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0 (blank)     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Pyrimethamine; Sulphadiazine; Calcium folinate
Current Illness: Unknown
Preexisting Conditions: Congenital Toxoplasmosis; The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. No family history of intestinal invagination. There was a family functional colopathy.
Allergies:
Diagnostic Lab Data: Echography, 17Feb2008, Abnormal; 17 February 2008: The echography revealed an ileocaecal intestinal invagination with mesenteric ganglions. Reduction of invagination by gastrografin enema, controlled on post reduction echography.
CDC 'Split Type': B0509703A

Write-up: This case was reported by a physician, via a GSK sales representative and described the occurrence of invagination of intestine in a 3-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Concurrent medical condition included treated congenital toxoplasmosis (NOS). The subject had no past medical condition of intestinal malformation and intestinal invagination. There was a family functional colopathy. In February 2008, the subject received a 1st dose of ROTARIX (batch number not available). On 17 February 2008, 14 days after vaccination with ROTARIX, the subject was hospitalized. At the echography, a diagnosis of ileocaecal invagination of intestine with mesenteric ganglions was made. The subject was treated with enema and the subject recovered. The hospital physicians evoked a possible relation between toxoplasmosis and mesenteric ganglions. The physician considered the events were unrelated to vaccination with ROTARIX (temporal association but non causal). Follow up received on 12 March 2008: The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. There was no family history of intestinal invagination. Medical condition included congenital toxoplasmosis (maternal antibodies became positive during the pregnancy), treated with ADIAZINE and pyrimethamine since birth. On 12 February 2008, the subject received a first dose of ROTARIX (batch number A41CA526A) and a dose of INFANRIX QUINTA (batch number A20CA391B, right gluteal, subcutaneous). Five days later, on 17 February 2008, the subject developed moderate occlusive syndrome (intestinal obstruction) with vomiting and cessation of feces and flatus. Diagnosis of acute intestinal (ileocaecum) invagination was made on echography. No abdominal scan and X-ray was performed. The intestinal invagination was reduced by gastrografin enema, controlled on post reduction echography. ROTARIX has not been readministered. The reporter considered that the events were possibly related to vaccination


Changed on 8/31/2010

VAERS ID: 384838 Before After
VAERS Form:
Age:0.3
Sex:Female
Location:Foreign
Vaccinated:2008-02-12
Onset:2008-02-17
Submitted:2010-04-09
Entered:2010-04-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPIPVHIB: DTAP + IPV + HIB (UNKNOWN) DTAP + IPV + HIB (NO BRAND NAME) / GLAXOSMITHKLINE BIOLOGICALS (UNKNOWN) A20CA391B / - GM / SC
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA526A / 0 - / PO

Administered by: Other      Purchased by: Other
Symptoms: Apathy, Barium double contrast, Diet refusal, Echography abnormal, Flatulence, Intussusception, Vomiting, Subileus, Bowel movement irregularity

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Pyrimethamine; Sulphadiazine; Calcium folinate
Current Illness: Unknown
Preexisting Conditions: Congenital Toxoplasmosis; The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. No family history of intestinal invagination. There was a family functional colopathy.
Allergies:
Diagnostic Lab Data: Echography, 17Feb2008, Abnormal; 17 February 2008: The echography revealed an ileocaecal intestinal invagination with mesenteric ganglions. Reduction of invagination by gastrografin enema, controlled on post reduction echography.
CDC 'Split Type': B0509703A

Write-up: This case was reported by a physician, via a GSK sales representative and described the occurrence of invagination of intestine in a 3-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Concurrent medical condition included treated congenital toxoplasmosis (NOS). The subject had no past medical condition of intestinal malformation and intestinal invagination. There was a family functional colopathy. In February 2008, the subject received a 1st dose of ROTARIX (batch number not available). On 17 February 2008, 14 days after vaccination with ROTARIX, the subject was hospitalized. At the echography, a diagnosis of ileocaecal invagination of intestine with mesenteric ganglions was made. The subject was treated with enema and the subject recovered. The hospital physicians evoked a possible relation between toxoplasmosis and mesenteric ganglions. The physician considered the events were unrelated to vaccination with ROTARIX (temporal association but non causal). Follow up received on 12 March 2008: The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. There was no family history of intestinal invagination. Medical condition included congenital toxoplasmosis (maternal antibodies became positive during the pregnancy), treated with ADIAZINE and pyrimethamine since birth. On 12 February 2008, the subject received a first dose of ROTARIX (batch number A41CA526A) and a dose of INFANRIX QUINTA (batch number A20CA391B, right gluteal, subcutaneous). Five days later, on 17 February 2008, the subject developed moderate occlusive syndrome (intestinal obstruction) with vomiting and cessation of feces and flatus. Diagnosis of acute intestinal (ileocaecum) invagination was made on echography. No abdominal scan and X-ray was performed. The intestinal invagination was reduced by gastrografin enema, controlled on post reduction echography. ROTARIX has not been readministered. The reporter considered that the events were possibly related to vaccination


Changed on 11/3/2010

VAERS ID: 384838 Before After
VAERS Form:
Age:0.3
Sex:Female
Location:Foreign
Vaccinated:2008-02-12
Onset:2008-02-17
Submitted:2010-04-09
Entered:2010-04-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPIPVHIB: DTAP + IPV + HIB (NO BRAND NAME) DTAP + IPV + HIB (FOREIGN) / GLAXOSMITHKLINE BIOLOGICALS (UNKNOWN) A20CA391B / - GM / SC
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA526A / 0 - / PO

Administered by: Other      Purchased by: Other
Symptoms: Apathy, Barium double contrast, Diet refusal, Echography abnormal, Flatulence, Intussusception, Vomiting, Subileus, Bowel movement irregularity

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Pyrimethamine; Sulphadiazine; Calcium folinate
Current Illness: Unknown
Preexisting Conditions: Congenital Toxoplasmosis; The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. No family history of intestinal invagination. There was a family functional colopathy.
Allergies:
Diagnostic Lab Data: Echography, 17Feb2008, Abnormal; 17 February 2008: The echography revealed an ileocaecal intestinal invagination with mesenteric ganglions. Reduction of invagination by gastrografin enema, controlled on post reduction echography.
CDC 'Split Type': B0509703A

Write-up: This case was reported by a physician, via a GSK sales representative and described the occurrence of invagination of intestine in a 3-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Concurrent medical condition included treated congenital toxoplasmosis (NOS). The subject had no past medical condition of intestinal malformation and intestinal invagination. There was a family functional colopathy. In February 2008, the subject received a 1st dose of ROTARIX (batch number not available). On 17 February 2008, 14 days after vaccination with ROTARIX, the subject was hospitalized. At the echography, a diagnosis of ileocaecal invagination of intestine with mesenteric ganglions was made. The subject was treated with enema and the subject recovered. The hospital physicians evoked a possible relation between toxoplasmosis and mesenteric ganglions. The physician considered the events were unrelated to vaccination with ROTARIX (temporal association but non causal). Follow up received on 12 March 2008: The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. There was no family history of intestinal invagination. Medical condition included congenital toxoplasmosis (maternal antibodies became positive during the pregnancy), treated with ADIAZINE and pyrimethamine since birth. On 12 February 2008, the subject received a first dose of ROTARIX (batch number A41CA526A) and a dose of INFANRIX QUINTA (batch number A20CA391B, right gluteal, subcutaneous). Five days later, on 17 February 2008, the subject developed moderate occlusive syndrome (intestinal obstruction) with vomiting and cessation of feces and flatus. Diagnosis of acute intestinal (ileocaecum) invagination was made on echography. No abdominal scan and X-ray was performed. The intestinal invagination was reduced by gastrografin enema, controlled on post reduction echography. ROTARIX has not been readministered. The reporter considered that the events were possibly related to vaccination


Changed on 1/4/2011

VAERS ID: 384838 Before After
VAERS Form:
Age:0.3
Sex:Female
Location:Foreign
Vaccinated:2008-02-12
Onset:2008-02-17
Submitted:2010-04-09
Entered:2010-04-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPIPVHIB: DTAP + IPV + HIB (FOREIGN) / GLAXOSMITHKLINE BIOLOGICALS (UNKNOWN) GLAXOSMITHKLINE BIOLOGICALS A20CA391B / - GM / SC
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA526A / 0 - / PO

Administered by: Other      Purchased by: Other
Symptoms: Apathy, Barium double contrast, Diet refusal, Echography abnormal, Flatulence, Intussusception, Vomiting, Subileus, Bowel movement irregularity

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Pyrimethamine; Sulphadiazine; Calcium folinate
Current Illness: Unknown
Preexisting Conditions: Congenital Toxoplasmosis; The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. No family history of intestinal invagination. There was a family functional colopathy.
Allergies:
Diagnostic Lab Data: Echography, 17Feb2008, Abnormal; 17 February 2008: The echography revealed an ileocaecal intestinal invagination with mesenteric ganglions. Reduction of invagination by gastrografin enema, controlled on post reduction echography.
CDC 'Split Type': B0509703A

Write-up: This case was reported by a physician, via a GSK sales representative and described the occurrence of invagination of intestine in a 3-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Concurrent medical condition included treated congenital toxoplasmosis (NOS). The subject had no past medical condition of intestinal malformation and intestinal invagination. There was a family functional colopathy. In February 2008, the subject received a 1st dose of ROTARIX (batch number not available). On 17 February 2008, 14 days after vaccination with ROTARIX, the subject was hospitalized. At the echography, a diagnosis of ileocaecal invagination of intestine with mesenteric ganglions was made. The subject was treated with enema and the subject recovered. The hospital physicians evoked a possible relation between toxoplasmosis and mesenteric ganglions. The physician considered the events were unrelated to vaccination with ROTARIX (temporal association but non causal). Follow up received on 12 March 2008: The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. There was no family history of intestinal invagination. Medical condition included congenital toxoplasmosis (maternal antibodies became positive during the pregnancy), treated with ADIAZINE and pyrimethamine since birth. On 12 February 2008, the subject received a first dose of ROTARIX (batch number A41CA526A) and a dose of INFANRIX QUINTA (batch number A20CA391B, right gluteal, subcutaneous). Five days later, on 17 February 2008, the subject developed moderate occlusive syndrome (intestinal obstruction) with vomiting and cessation of feces and flatus. Diagnosis of acute intestinal (ileocaecum) invagination was made on echography. No abdominal scan and X-ray was performed. The intestinal invagination was reduced by gastrografin enema, controlled on post reduction echography. ROTARIX has not been readministered. The reporter considered that the events were possibly related to vaccination with ROTARIX. Upon follow-up received from the agency (PB20080160) on 02 April 2010: Concurrent medication included ADIAZINE (500 mg/kg/day), MALOCIDE (2/5 mg/kg/day) and FOLINORAL (50 mg/kg/day) since birth. These drugs have not been stopped following the events. On 17 February 2008, the subject was admitted at hospital due to apathy and refusal to eat during more than 12 hours. Clinical course was favorable after enema. The subject recovered without sequelae in 48 hours. According to the foreign method of assessment, the causal relationship, between the reported events and vaccination with ROTARIX was dubious. This case has been closed; no more information will be available.


Changed on 5/13/2013

VAERS ID: 384838 Before After
VAERS Form:
Age:0.3
Sex:Female
Location:Foreign
Vaccinated:2008-02-12
Onset:2008-02-17
Submitted:2010-04-09
Entered:2010-04-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPIPVHIB: DTAP + IPV + HIB (FOREIGN) / GLAXOSMITHKLINE BIOLOGICALS A20CA391B / - GM / SC
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA526A / 0 - / PO
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA526A / 0 - / PO

Administered by: Other      Purchased by: Other
Symptoms: Apathy, Barium double contrast, Diet refusal, Echography abnormal, Flatulence, Intussusception, Vomiting, Subileus, Bowel movement irregularity

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Pyrimethamine; Sulphadiazine; Calcium folinate
Current Illness: Unknown
Preexisting Conditions: Congenital Toxoplasmosis; The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. No family history of intestinal invagination. There was a family functional colopathy.
Allergies:
Diagnostic Lab Data: Echography, 17Feb2008, Abnormal; 17 February 2008: The echography revealed an ileocaecal intestinal invagination with mesenteric ganglions. Reduction of invagination by gastrografin enema, controlled on post reduction echography.
CDC 'Split Type': B0509703A

Write-up: This case was reported by a physician, via a GSK sales representative and described the occurrence of invagination of intestine in a 3-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Concurrent medical condition included treated congenital toxoplasmosis (NOS). The subject had no past medical condition of intestinal malformation and intestinal invagination. There was a family functional colopathy. In February 2008, the subject received a 1st dose of ROTARIX (batch number not available). On 17 February 2008, 14 days after vaccination with ROTARIX, the subject was hospitalized. At the echography, a diagnosis of ileocaecal invagination of intestine with mesenteric ganglions was made. The subject was treated with enema and the subject recovered. The hospital physicians evoked a possible relation between toxoplasmosis and mesenteric ganglions. The physician considered the events were unrelated to vaccination with ROTARIX (temporal association but non causal). Follow up received on 12 March 2008: The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. There was no family history of intestinal invagination. Medical condition included congenital toxoplasmosis (maternal antibodies became positive during the pregnancy), treated with ADIAZINE and pyrimethamine since birth. On 12 February 2008, the subject received a first dose of ROTARIX (batch number A41CA526A) and a dose of INFANRIX QUINTA (batch number A20CA391B, right gluteal, subcutaneous). Five days later, on 17 February 2008, the subject developed moderate occlusive syndrome (intestinal obstruction) with vomiting and cessation of feces and flatus. Diagnosis of acute intestinal (ileocaecum) invagination was made on echography. No abdominal scan and X-ray was performed. The intestinal invagination was reduced by gastrografin enema, controlled on post reduction echography. ROTARIX has not been readministered. The reporter considered that the events were possibly related to vaccination with ROTARIX. Upon follow-up received from the agency (PB20080160) on 02 April 2010: Concurrent medication included ADIAZINE (500 mg/kg/day), MALOCIDE (2/5 mg/kg/day) and FOLINORAL (50 mg/kg/day) since birth. These drugs have not been stopped following the events. On 17 February 2008, the subject was admitted at hospital due to apathy and refusal to eat during more than 12 hours. Clinical course was favorable after enema. The subject recovered without sequelae in 48 hours. According to the foreign method of assessment, the causal relationship, between the reported events and vaccination with ROTARIX was dubious. This case has been closed; no more information will be available.


Changed on 6/14/2014

VAERS ID: 384838 Before After
VAERS Form:
Age:0.3
Sex:Female
Location:Foreign
Vaccinated:2008-02-12
Onset:2008-02-17
Submitted:2010-04-09
Entered:2010-04-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPIPVHIB: DTAP + IPV + HIB (FOREIGN) / GLAXOSMITHKLINE BIOLOGICALS A20CA391B / - GM / SC
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA526A / 0 - / PO

Administered by: Other      Purchased by: Other
Symptoms: Apathy, Barium double contrast, Diet refusal, Echography abnormal, Flatulence, Intussusception, Vomiting, Subileus, Bowel movement irregularity

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Pyrimethamine; Sulphadiazine; Calcium folinate
Current Illness: Unknown
Preexisting Conditions: Congenital Toxoplasmosis; The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. No family history of intestinal invagination. There was a family functional colopathy.
Allergies:
Diagnostic Lab Data: Echography, 17Feb2008, Abnormal; 17 February 2008: The echography revealed an ileocaecal intestinal invagination with mesenteric ganglions. Reduction of invagination by gastrografin enema, controlled on post reduction echography.
CDC 'Split Type': B0509703A

Write-up: This case was reported by a physician, via a GSK sales representative and described the occurrence of invagination of intestine in a 3-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Concurrent medical condition included treated congenital toxoplasmosis (NOS). The subject had no past medical condition of intestinal malformation and intestinal invagination. There was a family functional colopathy. In February 2008, the subject received a 1st dose of ROTARIX (batch number not available). On 17 February 2008, 14 days after vaccination with ROTARIX, the subject was hospitalized. At the echography, a diagnosis of ileocaecal invagination of intestine with mesenteric ganglions was made. The subject was treated with enema and the subject recovered. The hospital physicians evoked a possible relation between toxoplasmosis and mesenteric ganglions. The physician considered the events were unrelated to vaccination with ROTARIX (temporal association but non causal). Follow up received on 12 March 2008: The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. There was no family history of intestinal invagination. Medical condition included congenital toxoplasmosis (maternal antibodies became positive during the pregnancy), treated with ADIAZINE and pyrimethamine since birth. On 12 February 2008, the subject received a first dose of ROTARIX (batch number A41CA526A) and a dose of INFANRIX QUINTA (batch number A20CA391B, right gluteal, subcutaneous). Five days later, on 17 February 2008, the subject developed moderate occlusive syndrome (intestinal obstruction) with vomiting and cessation of feces and flatus. Diagnosis of acute intestinal (ileocaecum) invagination was made on echography. No abdominal scan and X-ray was performed. The intestinal invagination was reduced by gastrografin enema, controlled on post reduction echography. ROTARIX has not been readministered. The reporter considered that the events were possibly related to vaccination with ROTARIX. Upon follow-up received from the agency (PB20080160) on 02 April 2010: Concurrent medication included ADIAZINE (500 mg/kg/day), MALOCIDE (2/5 mg/kg/day) and FOLINORAL (50 mg/kg/day) since birth. These drugs have not been stopped following the events. On 17 February 2008, the subject was admitted at hospital due to apathy and refusal to eat during more than 12 hours. Clinical course was favorable after enema. The subject recovered without sequelae in 48 hours. According to the foreign method of assessment, the causal relationship, between the reported events and vaccination with ROTARIX was dubious. This case has been closed; no more information will be available.


Changed on 2/14/2017

VAERS ID: 384838 Before After
VAERS Form:
Age:0.3 0.25
Sex:Female
Location:Foreign
Vaccinated:2008-02-12
Onset:2008-02-17
Submitted:2010-04-09
Entered:2010-04-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPIPVHIB: DTAP + IPV + HIB (FOREIGN) / GLAXOSMITHKLINE BIOLOGICALS A20CA391B / - GM / SC
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA526A / 0 - / PO

Administered by: Other      Purchased by: Other
Symptoms: Apathy, Barium double contrast, Diet refusal, Echography abnormal, Flatulence, Intussusception, Vomiting, Subileus, Bowel movement irregularity

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: Congenital Toxoplasmosis; The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. No family history of intestinal invagination. There was a family functional colopathy.
Allergies:
Diagnostic Lab Data: Echography, 17Feb2008, Abnormal; 17 February 2008: The echography revealed an ileocaecal intestinal invagination with mesenteric ganglions. Reduction of invagination by gastrografin enema, controlled on post reduction echography.
CDC 'Split Type': B0509703A

Write-up: This case was reported by a physician, via a GSK sales representative and described the occurrence of invagination of intestine in a 3-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Concurrent medical condition included treated congenital toxoplasmosis (NOS). The subject had no past medical condition of intestinal malformation and intestinal invagination. There was a family functional colopathy. In February 2008, the subject received a 1st dose of ROTARIX (batch number not available). On 17 February 2008, 14 days after vaccination with ROTARIX, the subject was hospitalized. At the echography, a diagnosis of ileocaecal invagination of intestine with mesenteric ganglions was made. The subject was treated with enema and the subject recovered. The hospital physicians evoked a possible relation between toxoplasmosis and mesenteric ganglions. The physician considered the events were unrelated to vaccination with ROTARIX (temporal association but non causal). Follow up received on 12 March 2008: The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. There was no family history of intestinal invagination. Medical condition included congenital toxoplasmosis (maternal antibodies became positive during the pregnancy), treated with ADIAZINE and pyrimethamine since birth. On 12 February 2008, the subject received a first dose of ROTARIX (batch number A41CA526A) and a dose of INFANRIX QUINTA (batch number A20CA391B, right gluteal, subcutaneous). Five days later, on 17 February 2008, the subject developed moderate occlusive syndrome (intestinal obstruction) with vomiting and cessation of feces and flatus. Diagnosis of acute intestinal (ileocaecum) invagination was made on echography. No abdominal scan and X-ray was performed. The intestinal invagination was reduced by gastrografin enema, controlled on post reduction echography. ROTARIX has not been readministered. The reporter considered that the events were possibly related to vaccination with ROTARIX. Upon follow-up received from the agency (PB20080160) on 02 April 2010: Concurrent medication included ADIAZINE (500 mg/kg/day), MALOCIDE (2/5 mg/kg/day) and FOLINORAL (50 mg/kg/day) since birth. These drugs have not been stopped following the events. On 17 February 2008, the subject was admitted at hospital due to apathy and refusal to eat during more than 12 hours. Clinical course was favorable after enema. The subject recovered without sequelae in 48 hours. According to the foreign method of assessment, the causal relationship, between the reported events and vaccination with ROTARIX was dubious. This case has been closed; no more information will be available.


Changed on 4/14/2017

VAERS ID: 384838 Before After
VAERS Form:
Age:0.25
Sex:Female
Location:Foreign
Vaccinated:2008-02-12
Onset:2008-02-17
Submitted:2010-04-09
Entered:2010-04-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPIPVHIB: DTAP + IPV + HIB (FOREIGN) / GLAXOSMITHKLINE BIOLOGICALS A20CA391B / - GM / SC
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA526A / 0 - / PO

Administered by: Other      Purchased by: Other
Symptoms: Apathy, Barium double contrast, Diet refusal, Echography abnormal, Flatulence, Intussusception, Vomiting, Subileus, Bowel movement irregularity

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Pyrimethamine; Sulphadiazine; Calcium folinate
Current Illness: Unknown
Preexisting Conditions: Congenital Toxoplasmosis; The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. No family history of intestinal invagination. There was a family functional colopathy.
Allergies:
Diagnostic Lab Data: Echography, 17Feb2008, Abnormal; 17 February 2008: The echography revealed an ileocaecal intestinal invagination with mesenteric ganglions. Reduction of invagination by gastrografin enema, controlled on post reduction echography.
CDC 'Split Type': B0509703A

Write-up: This case was reported by a physician, via a GSK sales representative and described the occurrence of invagination of intestine in a 3-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Concurrent medical condition included treated congenital toxoplasmosis (NOS). The subject had no past medical condition of intestinal malformation and intestinal invagination. There was a family functional colopathy. In February 2008, the subject received a 1st dose of ROTARIX (batch number not available). On 17 February 2008, 14 days after vaccination with ROTARIX, the subject was hospitalized. At the echography, a diagnosis of ileocaecal invagination of intestine with mesenteric ganglions was made. The subject was treated with enema and the subject recovered. The hospital physicians evoked a possible relation between toxoplasmosis and mesenteric ganglions. The physician considered the events were unrelated to vaccination with ROTARIX (temporal association but non causal). Follow up received on 12 March 2008: The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. There was no family history of intestinal invagination. Medical condition included congenital toxoplasmosis (maternal antibodies became positive during the pregnancy), treated with ADIAZINE and pyrimethamine since birth. On 12 February 2008, the subject received a first dose of ROTARIX (batch number A41CA526A) and a dose of INFANRIX QUINTA (batch number A20CA391B, right gluteal, subcutaneous). Five days later, on 17 February 2008, the subject developed moderate occlusive syndrome (intestinal obstruction) with vomiting and cessation of feces and flatus. Diagnosis of acute intestinal (ileocaecum) invagination was made on echography. No abdominal scan and X-ray was performed. The intestinal invagination was reduced by gastrografin enema, controlled on post reduction echography. ROTARIX has not been readministered. The reporter considered that the events were possibly related to vaccination with ROTARIX. Upon follow-up received from the agency (PB20080160) on 02 April 2010: Concurrent medication included ADIAZINE (500 mg/kg/day), MALOCIDE (2/5 mg/kg/day) and FOLINORAL (50 mg/kg/day) since birth. These drugs have not been stopped following the events. On 17 February 2008, the subject was admitted at hospital due to apathy and refusal to eat during more than 12 hours. Clinical course was favorable after enema. The subject recovered without sequelae in 48 hours. According to the foreign method of assessment, the causal relationship, between the reported events and vaccination with ROTARIX was dubious. This case has been closed; no more information will be available.


Changed on 5/14/2017

VAERS ID: 384838 Before After
VAERS Form:
Age:0.25
Sex:Female
Location:Foreign
Vaccinated:2008-02-12
Onset:2008-02-17
Submitted:2010-04-09
Entered:2010-04-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPIPVHIB: DTAP + IPV + HIB (FOREIGN) DTAP + IPV + HIB (INFANRIX QUINTA) / GLAXOSMITHKLINE BIOLOGICALS A20CA391B / - GM / SC
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA526A / 0 - / PO

Administered by: Other      Purchased by: Other
Symptoms: Apathy, Barium double contrast, Diet refusal, Echography abnormal, Flatulence, Intussusception, Vomiting, Subileus, Bowel movement irregularity

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Pyrimethamine; Sulphadiazine; Calcium folinate
Current Illness: Unknown
Preexisting Conditions: Congenital Toxoplasmosis; The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. No family history of intestinal invagination. There was a family functional colopathy.
Allergies:
Diagnostic Lab Data: Echography, 17Feb2008, Abnormal; 17 February 2008: The echography revealed an ileocaecal intestinal invagination with mesenteric ganglions. Reduction of invagination by gastrografin enema, controlled on post reduction echography.
CDC 'Split Type': B0509703A

Write-up: This case was reported by a physician, via a GSK sales representative and described the occurrence of invagination of intestine in a 3-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Concurrent medical condition included treated congenital toxoplasmosis (NOS). The subject had no past medical condition of intestinal malformation and intestinal invagination. There was a family functional colopathy. In February 2008, the subject received a 1st dose of ROTARIX (batch number not available). On 17 February 2008, 14 days after vaccination with ROTARIX, the subject was hospitalized. At the echography, a diagnosis of ileocaecal invagination of intestine with mesenteric ganglions was made. The subject was treated with enema and the subject recovered. The hospital physicians evoked a possible relation between toxoplasmosis and mesenteric ganglions. The physician considered the events were unrelated to vaccination with ROTARIX (temporal association but non causal). Follow up received on 12 March 2008: The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. There was no family history of intestinal invagination. Medical condition included congenital toxoplasmosis (maternal antibodies became positive during the pregnancy), treated with ADIAZINE and pyrimethamine since birth. On 12 February 2008, the subject received a first dose of ROTARIX (batch number A41CA526A) and a dose of INFANRIX QUINTA (batch number A20CA391B, right gluteal, subcutaneous). Five days later, on 17 February 2008, the subject developed moderate occlusive syndrome (intestinal obstruction) with vomiting and cessation of feces and flatus. Diagnosis of acute intestinal (ileocaecum) invagination was made on echography. No abdominal scan and X-ray was performed. The intestinal invagination was reduced by gastrografin enema, controlled on post reduction echography. ROTARIX has not been readministered. The reporter considered that the events were possibly related to vaccination with ROTARIX. Upon follow-up received from the agency (PB20080160) on 02 April 2010: Concurrent medication included ADIAZINE (500 mg/kg/day), MALOCIDE (2/5 mg/kg/day) and FOLINORAL (50 mg/kg/day) since birth. These drugs have not been stopped following the events. On 17 February 2008, the subject was admitted at hospital due to apathy and refusal to eat during more than 12 hours. Clinical course was favorable after enema. The subject recovered without sequelae in 48 hours. According to the foreign method of assessment, the causal relationship, between the reported events and vaccination with ROTARIX was dubious. This case has been closed; no more information will be available.


Changed on 9/14/2017

VAERS ID: 384838 Before After
VAERS Form:(blank) 1
Age:0.25
Sex:Female
Location:Foreign
Vaccinated:2008-02-12
Onset:2008-02-17
Submitted:2010-04-09
Entered:2010-04-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPIPVHIB: DTAP + IPV + HIB (INFANRIX QUINTA) / GLAXOSMITHKLINE BIOLOGICALS A20CA391B / - UNK GM / SC
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA526A / 0 1 - MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Apathy, Barium double contrast, Diet refusal, Echography abnormal, Flatulence, Intussusception, Vomiting, Subileus, Bowel movement irregularity

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Pyrimethamine; Sulphadiazine; Calcium folinate
Current Illness: Unknown
Preexisting Conditions: Congenital Toxoplasmosis; The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. No family history of intestinal invagination. There was a family functional colopathy.
Allergies:
Diagnostic Lab Data: Echography, 17Feb2008, Abnormal; 17 February 2008: The echography revealed an ileocaecal intestinal invagination with mesenteric ganglions. Reduction of invagination by gastrografin enema, controlled on post reduction echography.
CDC 'Split Type': B0509703A

Write-up: This case was reported by a physician, via a GSK sales representative and described the occurrence of invagination of intestine in a 3-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Concurrent medical condition included treated congenital toxoplasmosis (NOS). The subject had no past medical condition of intestinal malformation and intestinal invagination. There was a family functional colopathy. In February 2008, the subject received a 1st dose of ROTARIX (batch number not available). On 17 February 2008, 14 days after vaccination with ROTARIX, the subject was hospitalized. At the echography, a diagnosis of ileocaecal invagination of intestine with mesenteric ganglions was made. The subject was treated with enema and the subject recovered. The hospital physicians evoked a possible relation between toxoplasmosis and mesenteric ganglions. The physician considered the events were unrelated to vaccination with ROTARIX (temporal association but non causal). Follow up received on 12 March 2008: The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. There was no family history of intestinal invagination. Medical condition included congenital toxoplasmosis (maternal antibodies became positive during the pregnancy), treated with ADIAZINE and pyrimethamine since birth. On 12 February 2008, the subject received a first dose of ROTARIX (batch number A41CA526A) and a dose of INFANRIX QUINTA (batch number A20CA391B, right gluteal, subcutaneous). Five days later, on 17 February 2008, the subject developed moderate occlusive syndrome (intestinal obstruction) with vomiting and cessation of feces and flatus. Diagnosis of acute intestinal (ileocaecum) invagination was made on echography. No abdominal scan and X-ray was performed. The intestinal invagination was reduced by gastrografin enema, controlled on post reduction echography. ROTARIX has not been readministered. The reporter considered that the events were possibly related to vaccination with ROTARIX. Upon follow-up received from the agency (PB20080160) on 02 April 2010: Concurrent medication included ADIAZINE (500 mg/kg/day), MALOCIDE (2/5 mg/kg/day) and FOLINORAL (50 mg/kg/day) since birth. These drugs have not been stopped following the events. On 17 February 2008, the subject was admitted at hospital due to apathy and refusal to eat during more than 12 hours. Clinical course was favorable after enema. The subject recovered without sequelae in 48 hours. According to the foreign method of assessment, the causal relationship, between the reported events and vaccination with ROTARIX was dubious. This case has been closed; no more information will be available.


Changed on 2/14/2018

VAERS ID: 384838 Before After
VAERS Form:1
Age:0.25
Sex:Female
Location:Foreign
Vaccinated:2008-02-12
Onset:2008-02-17
Submitted:2010-04-09
Entered:2010-04-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPIPVHIB: DTAP + IPV + HIB (INFANRIX QUINTA) / GLAXOSMITHKLINE BIOLOGICALS A20CA391B / UNK GM / SC
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA526A / 1 MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Apathy, Barium double contrast, Diet refusal, Echography abnormal, Flatulence, Intussusception, Vomiting, Subileus, Bowel movement irregularity

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Pyrimethamine; Sulphadiazine; Calcium folinate
Current Illness: Unknown
Preexisting Conditions: Congenital Toxoplasmosis; The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. No family history of intestinal invagination. There was a family functional colopathy.
Allergies:
Diagnostic Lab Data: Echography, 17Feb2008, Abnormal; 17 February 2008: The echography revealed an ileocaecal intestinal invagination with mesenteric ganglions. Reduction of invagination by gastrografin enema, controlled on post reduction echography.
CDC 'Split Type': B0509703A

Write-up: This case was reported by a physician, via a GSK sales representative and described the occurrence of invagination of intestine in a 3-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Concurrent medical condition included treated congenital toxoplasmosis (NOS). The subject had no past medical condition of intestinal malformation and intestinal invagination. There was a family functional colopathy. In February 2008, the subject received a 1st dose of ROTARIX (batch number not available). On 17 February 2008, 14 days after vaccination with ROTARIX, the subject was hospitalized. At the echography, a diagnosis of ileocaecal invagination of intestine with mesenteric ganglions was made. The subject was treated with enema and the subject recovered. The hospital physicians evoked a possible relation between toxoplasmosis and mesenteric ganglions. The physician considered the events were unrelated to vaccination with ROTARIX (temporal association but non causal). Follow up received on 12 March 2008: The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. There was no family history of intestinal invagination. Medical condition included congenital toxoplasmosis (maternal antibodies became positive during the pregnancy), treated with ADIAZINE and pyrimethamine since birth. On 12 February 2008, the subject received a first dose of ROTARIX (batch number A41CA526A) and a dose of INFANRIX QUINTA (batch number A20CA391B, right gluteal, subcutaneous). Five days later, on 17 February 2008, the subject developed moderate occlusive syndrome (intestinal obstruction) with vomiting and cessation of feces and flatus. Diagnosis of acute intestinal (ileocaecum) invagination was made on echography. No abdominal scan and X-ray was performed. The intestinal invagination was reduced by gastrografin enema, controlled on post reduction echography. ROTARIX has not been readministered. The reporter considered that the events were possibly related to vaccination with ROTARIX. Upon follow-up received from the agency (PB20080160) on 02 April 2010: Concurrent medication included ADIAZINE (500 mg/kg/day), MALOCIDE (2/5 mg/kg/day) and FOLINORAL (50 mg/kg/day) since birth. These drugs have not been stopped following the events. On 17 February 2008, the subject was admitted at hospital due to apathy and refusal to eat during more than 12 hours. Clinical course was favorable after enema. The subject recovered without sequelae in 48 hours. According to the foreign method of assessment, the causal relationship, between the reported events and vaccination with ROTARIX was dubious. This case has been closed; no more information will be available.


Changed on 6/14/2018

VAERS ID: 384838 Before After
VAERS Form:1
Age:0.25
Sex:Female
Location:Foreign
Vaccinated:2008-02-12
Onset:2008-02-17
Submitted:2010-04-09
Entered:2010-04-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPIPVHIB: DTAP + IPV + HIB (INFANRIX QUINTA) / GLAXOSMITHKLINE BIOLOGICALS A20CA391B / UNK GM / SC
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA526A / 1 MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Apathy, Barium double contrast, Diet refusal, Echography abnormal, Flatulence, Intussusception, Vomiting, Subileus, Bowel movement irregularity

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Pyrimethamine; Sulphadiazine; Calcium folinate
Current Illness: Unknown
Preexisting Conditions: Congenital Toxoplasmosis; The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. No family history of intestinal invagination. There was a family functional colopathy.
Allergies:
Diagnostic Lab Data: Echography, 17Feb2008, Abnormal; 17 February 2008: The echography revealed an ileocaecal intestinal invagination with mesenteric ganglions. Reduction of invagination by gastrografin enema, controlled on post reduction echography.
CDC 'Split Type': B0509703A

Write-up: This case was reported by a physician, via a GSK sales representative and described the occurrence of invagination of intestine in a 3-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Concurrent medical condition included treated congenital toxoplasmosis (NOS). The subject had no past medical condition of intestinal malformation and intestinal invagination. There was a family functional colopathy. In February 2008, the subject received a 1st dose of ROTARIX (batch number not available). On 17 February 2008, 14 days after vaccination with ROTARIX, the subject was hospitalized. At the echography, a diagnosis of ileocaecal invagination of intestine with mesenteric ganglions was made. The subject was treated with enema and the subject recovered. The hospital physicians evoked a possible relation between toxoplasmosis and mesenteric ganglions. The physician considered the events were unrelated to vaccination with ROTARIX (temporal association but non causal). Follow up received on 12 March 2008: The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. There was no family history of intestinal invagination. Medical condition included congenital toxoplasmosis (maternal antibodies became positive during the pregnancy), treated with ADIAZINE and pyrimethamine since birth. On 12 February 2008, the subject received a first dose of ROTARIX (batch number A41CA526A) and a dose of INFANRIX QUINTA (batch number A20CA391B, right gluteal, subcutaneous). Five days later, on 17 February 2008, the subject developed moderate occlusive syndrome (intestinal obstruction) with vomiting and cessation of feces and flatus. Diagnosis of acute intestinal (ileocaecum) invagination was made on echography. No abdominal scan and X-ray was performed. The intestinal invagination was reduced by gastrografin enema, controlled on post reduction echography. ROTARIX has not been readministered. The reporter considered that the events were possibly related to vaccination with ROTARIX. Upon follow-up received from the agency (PB20080160) on 02 April 2010: Concurrent medication included ADIAZINE (500 mg/kg/day), MALOCIDE (2/5 mg/kg/day) and FOLINORAL (50 mg/kg/day) since birth. These drugs have not been stopped following the events. On 17 February 2008, the subject was admitted at hospital due to apathy and refusal to eat during more than 12 hours. Clinical course was favorable after enema. The subject recovered without sequelae in 48 hours. According to the foreign method of assessment, the causal relationship, between the reported events and vaccination with ROTARIX was dubious. This case has been closed; no more information will be available.


Changed on 8/14/2018

VAERS ID: 384838 Before After
VAERS Form:1
Age:0.25
Sex:Female
Location:Foreign
Vaccinated:2008-02-12
Onset:2008-02-17
Submitted:2010-04-09
Entered:2010-04-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPIPVHIB: DTAP + IPV + HIB (INFANRIX QUINTA) / GLAXOSMITHKLINE BIOLOGICALS A20CA391B / UNK GM / SC
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA526A / 1 MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Apathy, Barium double contrast, Diet refusal, Echography abnormal, Flatulence, Intussusception, Vomiting, Subileus, Bowel movement irregularity

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Pyrimethamine; Sulphadiazine; Calcium folinate
Current Illness: Unknown
Preexisting Conditions: Congenital Toxoplasmosis; The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. No family history of intestinal invagination. There was a family functional colopathy.
Allergies:
Diagnostic Lab Data: Echography, 17Feb2008, Abnormal; 17 February 2008: The echography revealed an ileocaecal intestinal invagination with mesenteric ganglions. Reduction of invagination by gastrografin enema, controlled on post reduction echography.
CDC 'Split Type': B0509703A

Write-up: This case was reported by a physician, via a GSK sales representative and described the occurrence of invagination of intestine in a 3-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Concurrent medical condition included treated congenital toxoplasmosis (NOS). The subject had no past medical condition of intestinal malformation and intestinal invagination. There was a family functional colopathy. In February 2008, the subject received a 1st dose of ROTARIX (batch number not available). On 17 February 2008, 14 days after vaccination with ROTARIX, the subject was hospitalized. At the echography, a diagnosis of ileocaecal invagination of intestine with mesenteric ganglions was made. The subject was treated with enema and the subject recovered. The hospital physicians evoked a possible relation between toxoplasmosis and mesenteric ganglions. The physician considered the events were unrelated to vaccination with ROTARIX (temporal association but non causal). Follow up received on 12 March 2008: The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. There was no family history of intestinal invagination. Medical condition included congenital toxoplasmosis (maternal antibodies became positive during the pregnancy), treated with ADIAZINE and pyrimethamine since birth. On 12 February 2008, the subject received a first dose of ROTARIX (batch number A41CA526A) and a dose of INFANRIX QUINTA (batch number A20CA391B, right gluteal, subcutaneous). Five days later, on 17 February 2008, the subject developed moderate occlusive syndrome (intestinal obstruction) with vomiting and cessation of feces and flatus. Diagnosis of acute intestinal (ileocaecum) invagination was made on echography. No abdominal scan and X-ray was performed. The intestinal invagination was reduced by gastrografin enema, controlled on post reduction echography. ROTARIX has not been readministered. The reporter considered that the events were possibly related to vaccination with ROTARIX. Upon follow-up received from the agency (PB20080160) on 02 April 2010: Concurrent medication included ADIAZINE (500 mg/kg/day), MALOCIDE (2/5 mg/kg/day) and FOLINORAL (50 mg/kg/day) since birth. These drugs have not been stopped following the events. On 17 February 2008, the subject was admitted at hospital due to apathy and refusal to eat during more than 12 hours. Clinical course was favorable after enema. The subject recovered without sequelae in 48 hours. According to the foreign method of assessment, the causal relationship, between the reported events and vaccination with ROTARIX was dubious. This case has been closed; no more information will be available.


Changed on 9/14/2018

VAERS ID: 384838 Before After
VAERS Form:1
Age:0.25
Sex:Female
Location:Foreign
Vaccinated:2008-02-12
Onset:2008-02-17
Submitted:2010-04-09
Entered:2010-04-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPIPVHIB: DTAP + IPV + HIB (INFANRIX QUINTA) / GLAXOSMITHKLINE BIOLOGICALS A20CA391B / UNK GM / SC
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA526A / 1 MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Apathy, Barium double contrast, Diet refusal, Echography abnormal, Flatulence, Intussusception, Vomiting, Subileus, Bowel movement irregularity

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Pyrimethamine; Sulphadiazine; Calcium folinate
Current Illness: Unknown
Preexisting Conditions: Congenital Toxoplasmosis; The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. No family history of intestinal invagination. There was a family functional colopathy.
Allergies:
Diagnostic Lab Data: Echography, 17Feb2008, Abnormal; 17 February 2008: The echography revealed an ileocaecal intestinal invagination with mesenteric ganglions. Reduction of invagination by gastrografin enema, controlled on post reduction echography.
CDC 'Split Type': B0509703A

Write-up: This case was reported by a physician, via a GSK sales representative and described the occurrence of invagination of intestine in a 3-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Concurrent medical condition included treated congenital toxoplasmosis (NOS). The subject had no past medical condition of intestinal malformation and intestinal invagination. There was a family functional colopathy. In February 2008, the subject received a 1st dose of ROTARIX (batch number not available). On 17 February 2008, 14 days after vaccination with ROTARIX, the subject was hospitalized. At the echography, a diagnosis of ileocaecal invagination of intestine with mesenteric ganglions was made. The subject was treated with enema and the subject recovered. The hospital physicians evoked a possible relation between toxoplasmosis and mesenteric ganglions. The physician considered the events were unrelated to vaccination with ROTARIX (temporal association but non causal). Follow up received on 12 March 2008: The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. There was no family history of intestinal invagination. Medical condition included congenital toxoplasmosis (maternal antibodies became positive during the pregnancy), treated with ADIAZINE and pyrimethamine since birth. On 12 February 2008, the subject received a first dose of ROTARIX (batch number A41CA526A) and a dose of INFANRIX QUINTA (batch number A20CA391B, right gluteal, subcutaneous). Five days later, on 17 February 2008, the subject developed moderate occlusive syndrome (intestinal obstruction) with vomiting and cessation of feces and flatus. Diagnosis of acute intestinal (ileocaecum) invagination was made on echography. No abdominal scan and X-ray was performed. The intestinal invagination was reduced by gastrografin enema, controlled on post reduction echography. ROTARIX has not been readministered. The reporter considered that the events were possibly related to vaccination with ROTARIX. Upon follow-up received from the agency (PB20080160) on 02 April 2010: Concurrent medication included ADIAZINE (500 mg/kg/day), MALOCIDE (2/5 mg/kg/day) and FOLINORAL (50 mg/kg/day) since birth. These drugs have not been stopped following the events. On 17 February 2008, the subject was admitted at hospital due to apathy and refusal to eat during more than 12 hours. Clinical course was favorable after enema. The subject recovered without sequelae in 48 hours. According to the foreign method of assessment, the causal relationship, between the reported events and vaccination with ROTARIX was dubious. This case has been closed; no more information will be available.


Changed on 10/14/2018

VAERS ID: 384838 Before After
VAERS Form:1
Age:0.25
Sex:Female
Location:Foreign
Vaccinated:2008-02-12
Onset:2008-02-17
Submitted:2010-04-09
Entered:2010-04-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPIPVHIB: DTAP + IPV + HIB (INFANRIX QUINTA) / GLAXOSMITHKLINE BIOLOGICALS A20CA391B / UNK GM / SC
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA526A / 1 MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Apathy, Barium double contrast, Diet refusal, Echography abnormal, Flatulence, Intussusception, Vomiting, Subileus, Bowel movement irregularity

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Pyrimethamine; Sulphadiazine; Calcium folinate
Current Illness: Unknown
Preexisting Conditions: Congenital Toxoplasmosis; The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. No family history of intestinal invagination. There was a family functional colopathy.
Allergies:
Diagnostic Lab Data: Echography, 17Feb2008, Abnormal; 17 February 2008: The echography revealed an ileocaecal intestinal invagination with mesenteric ganglions. Reduction of invagination by gastrografin enema, controlled on post reduction echography.
CDC 'Split Type': B0509703A

Write-up: This case was reported by a physician, via a GSK sales representative and described the occurrence of invagination of intestine in a 3-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Concurrent medical condition included treated congenital toxoplasmosis (NOS). The subject had no past medical condition of intestinal malformation and intestinal invagination. There was a family functional colopathy. In February 2008, the subject received a 1st dose of ROTARIX (batch number not available). On 17 February 2008, 14 days after vaccination with ROTARIX, the subject was hospitalized. At the echography, a diagnosis of ileocaecal invagination of intestine with mesenteric ganglions was made. The subject was treated with enema and the subject recovered. The hospital physicians evoked a possible relation between toxoplasmosis and mesenteric ganglions. The physician considered the events were unrelated to vaccination with ROTARIX (temporal association but non causal). Follow up received on 12 March 2008: The subject had no past medical history of intestinal invagination, abdominal surgery and intestinal malformation. There was no family history of intestinal invagination. Medical condition included congenital toxoplasmosis (maternal antibodies became positive during the pregnancy), treated with ADIAZINE and pyrimethamine since birth. On 12 February 2008, the subject received a first dose of ROTARIX (batch number A41CA526A) and a dose of INFANRIX QUINTA (batch number A20CA391B, right gluteal, subcutaneous). Five days later, on 17 February 2008, the subject developed moderate occlusive syndrome (intestinal obstruction) with vomiting and cessation of feces and flatus. Diagnosis of acute intestinal (ileocaecum) invagination was made on echography. No abdominal scan and X-ray was performed. The intestinal invagination was reduced by gastrografin enema, controlled on post reduction echography. ROTARIX has not been readministered. The reporter considered that the events were possibly related to vaccination with ROTARIX. Upon follow-up received from the agency (PB20080160) on 02 April 2010: Concurrent medication included ADIAZINE (500 mg/kg/day), MALOCIDE (2/5 mg/kg/day) and FOLINORAL (50 mg/kg/day) since birth. These drugs have not been stopped following the events. On 17 February 2008, the subject was admitted at hospital due to apathy and refusal to eat during more than 12 hours. Clinical course was favorable after enema. The subject recovered without sequelae in 48 hours. According to the foreign method of assessment, the causal relationship, between the reported events and vaccination with ROTARIX was dubious. This case has been closed; no more information will be available.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=384838&WAYBACKHISTORY=ON


Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166